PUBLISHER: TechNavio | PRODUCT CODE: 2005558
PUBLISHER: TechNavio | PRODUCT CODE: 2005558
Global Aptamers Market 2026-2030
The global aptamers market is forecasted to grow by USD 8340872.0 thousand during 2025-2030, accelerating at a CAGR of 55.2% during the forecast period. The report on the global aptamers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strategic mainstreaming of ai-driven in-silico aptamer discovery, industrialization of ultra-sensitive diagnostics and point-of-care biosensing, structural expansion of therapeutics and aptamer-drug conjugates.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 41.7% |
| CAGR | 55.2% |
| Incremental Value | $8340872.0 thousand |
Technavio's global aptamers market is segmented as below:
By Application
- Therapeutics development
- Research and development
- Diagnostic
- Others
By Type
- Nucleic acid aptamers
- Peptide aptamers
By End-User
- Pharmaceutical and biotechnology companies
- Academic and government research institutes
- Contract research organizations
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the increase of generative AI and ml driven aptamer selection as one of the prime reasons driving the global aptamers market growth during the next few years. Also, growth of multivalent aptamer architectures and targeted radiopharmaceutical and integration of multi-faceted commercial licensing and enzyme-modulating proprietary will lead to sizable demand in the market.
The report on the global aptamers market covers the following areas:
- Global aptamers market sizing
- Global aptamers market forecast
- Global aptamers market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global aptamers market vendors that include 2bind GmbH, AMS Biotechnology Ltd., Aptadel Therapeutics, Aptagen LLC, Aptus Biotech S.L., Barrick Lab, Base Pair Biotechnologies Inc., Basking Biosciences Inc., Creative Biogene, NeoVentures Biotechnology Inc., Novaptech SAS, Oligo Factory, SomaLogic Inc., TriLink BioTechnologies, Veraptus, Vivonics Inc.. Also, the global aptamers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Aptamers Market 2020 - 2024
- Historic Market Size - Data Table on Global Aptamers Market 2020 - 2024 ($ thousand)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ thousand)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
- 6.1 Impact of AI in global aptamers market
- 6.2 Impact of geopolitical conflict for global aptamers market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Therapeutics development - Market size and forecast 2025-2030
- 8.4 Research and development - Market size and forecast 2025-2030
- 8.5 Diagnostic - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by Application
- Market opportunity by Application ($ thousand)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 Nucleic acid aptamers - Market size and forecast 2025-2030
- 9.4 Peptide aptamers - Market size and forecast 2025-2030
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ thousand)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
- 10.4 Academic and government research institutes - Market size and forecast 2025-2030
- 10.5 Contract research organizations - Market size and forecast 2025-2030
- 10.6 Others - Market size and forecast 2025-2030
- 10.7 Market opportunity by End-user
- Market opportunity by End-user ($ thousand)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 South Africa - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 Turkey - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Strategic mainstreaming of AI-driven in-silico aptamer discovery
- Industrialization of ultra-sensitive diagnostics and point-of-care biosensing
- Structural expansion of therapeutics and aptamer-drug conjugates
- 13.2 Market challenges
- Persistence of intellectual property thickets and freedom to operate
- Technical constraint of analytical-grade oligonucleotide synthesis capacity
- Clinical barrier of rapid renal clearance and pharmacokinetic optimization
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Increase of generative AI and ML driven aptamer selection
- Growth of multivalent aptamer architectures and targeted radiopharmaceutical
- Integration of multi-faceted commercial licensing and enzyme-modulating proprietary
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AMS Biotechnology Ltd.
- AMS Biotechnology Ltd. - Overview
- AMS Biotechnology Ltd. - Product / Service
- AMS Biotechnology Ltd. - Key offerings
- SWOT
- 15.5 Aptadel Therapeutics
- Aptadel Therapeutics - Overview
- Aptadel Therapeutics - Product / Service
- Aptadel Therapeutics - Key offerings
- SWOT
- 15.6 Aptagen LLC
- Aptagen LLC - Overview
- Aptagen LLC - Product / Service
- Aptagen LLC - Key offerings
- SWOT
- 15.7 Aptus Biotech S.L.
- Aptus Biotech S.L. - Overview
- Aptus Biotech S.L. - Product / Service
- Aptus Biotech S.L. - Key offerings
- SWOT
- 15.8 Barrick Lab
- Barrick Lab - Overview
- Barrick Lab - Product / Service
- Barrick Lab - Key offerings
- SWOT
- 15.9 Base Pair Biotechnologies Inc.
- Base Pair Biotechnologies Inc. - Overview
- Base Pair Biotechnologies Inc. - Product / Service
- Base Pair Biotechnologies Inc. - Key offerings
- SWOT
- 15.10 Basking Biosciences Inc.
- Basking Biosciences Inc. - Overview
- Basking Biosciences Inc. - Product / Service
- Basking Biosciences Inc. - Key offerings
- SWOT
- 15.11 Creative Biogene
- Creative Biogene - Overview
- Creative Biogene - Product / Service
- Creative Biogene - Key offerings
- SWOT
- 15.12 NeoVentures Biotechnology Inc.
- NeoVentures Biotechnology Inc. - Overview
- NeoVentures Biotechnology Inc. - Product / Service
- NeoVentures Biotechnology Inc. - Key offerings
- SWOT
- 15.13 Novaptech SAS
- Novaptech SAS - Overview
- Novaptech SAS - Product / Service
- Novaptech SAS - Key offerings
- SWOT
- 15.14 Oligo Factory
- Oligo Factory - Overview
- Oligo Factory - Product / Service
- Oligo Factory - Key offerings
- SWOT
- 15.15 SomaLogic Inc.
- SomaLogic Inc. - Overview
- SomaLogic Inc. - Product / Service
- SomaLogic Inc. - Key offerings
- SWOT
- 15.16 TriLink BioTechnologies
- TriLink BioTechnologies - Overview
- TriLink BioTechnologies - Product / Service
- TriLink BioTechnologies - Key offerings
- SWOT
- 15.17 Veraptus
- Veraptus - Overview
- Veraptus - Product / Service
- Veraptus - Key offerings
- SWOT
- 15.18 Vivonics Inc.
- Vivonics Inc. - Overview
- Vivonics Inc. - Product / Service
- Vivonics Inc. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
